Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25205 | AF710B | N/A | ≧98.0% ; EE≧98.0% |  |
| AF710B is a highly selective and potent allosteric agonist for M1 muscarinic and σ1 | ||||
| 25176 | AG-270 | 2201056-66-6 | ≧98.0% |  |
| MAT2A Inhibitor AG-270 is an orally available small molecule inhibitor of methionine | ||||
| 25173 | Anatibant (Synonyms: LF 16-0687; XY-2405) | 209733-45-9 | ≧98.0% | _209733-45-9.png) |
| 25172 | Amcasertib (Synonyms: BBI503) | 1129403-56-0 | ≧98.0% | _1129403-56-0.png) |
| 25171 | Alnodesertib ( Synonyms: ART0380 ) | 2267316-76-5 | ≧98.0% | .png) |
| 25159 | APS6-45 | 2188236-41-9 | 98% Min. |  |
| APS6-45 is a tumor calibrated inhibitor, showing unique polypharmacology. APS6-45 sho | ||||
| 25156 | ARN14494 | 1037837-27-6 | ≧98.0% |  |
| ARN14494 is a Selective Serine Palmitoyltransferase (SPT) Inhibitor which is a key en | ||||
| 25157 | ALT-007 | 2035010-37-6 | ≧98.0% |  |
| ALT-007 is an orally bioavailable SPT inhibitor that is more potent than myriocin, sa | ||||
| 25148 | Atebimetinib | 2669009-92-9 | ≧98.0% |  |
| Atebimetinib (IMM-1-104) is an oral, small-molecule allosteric inhibitor of the MEK1 | ||||
| 25145 | Atuzabrutinib | 1581714-49-9 | 98% Min. |  |
| Atuzabrutinib, also known as PRN 473, is a Bruton's tyrosine kinase inhibitor. | ||||
| 25144 | Andamertinib | 2254145-43-0 | 98% Min. |  |
| Andamertinib is an epidermal growth factor receptor tyrosine kinase inhibitor. It is | ||||
| 25136 | AC-003 | 2258671-03-1 | 98% Min. |  |
| 25134 | AZD-9750 | 3056515-10-4 | 98% Min. |  |
| 25133 | ARV-393 | 2851885-95-3 | 98% Min. |  |
| ARV-393 is an orally active PROTAC that utilizes the ubiquitin-proteasome system to t | ||||
| 25120 | Alixorexton | 2648347-56-0 | 98% Min. |  |
| Alixorexton, also known as TAK-994 or firazorexton, is a potent, orally bioavailable, | ||||
| 25112 | Ajulemic acid | 137945-48-3 | 98% Min. |  |
| 25111 | Afuresertib | 1047644-62-1 | 98% Min. |  |
| Afuresertib, also known as GSK-2110183 or GSK-2110183C, is an orally bioavailable inh | ||||
| 25110 | Aficamten | 2364554-48-1 | 98% Min. |  |
| Aficamten, also known as CK-3773274 and CK-274, is a Next-Generation Cardiac Myosin I | ||||
| 25109 | Admilparant | 2170126-74-4 | 98% Min. |  |
| Admilparant, also known as BMS-986278, is a potent lysophosphatidic acid receptor 1 ( | ||||
| 25108 | Avasopasem manganese | 435327-40-5 | 98% Min. |  |
| Avasopasem manganese, also known as GC-4419; M 40419 and SC-72325A, is a superoxide d | ||||
| 25071 | AT-007 | 2170729-29-8 | 98% Min. |  |
| AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase in | ||||
| 25033 | Azeliragon | 603148-36-3 | ≧98.0% |  |
| Azeliragon (TTP488) is an orally bioavailable small molecule inhibitor of the recepto | ||||
| 24152 | AKOS037652256 | 2171065-77-1 | 98% Min. |  |
| AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associat | ||||
| 24135 | AF-615 | 122510-61-6 | 98% Min. |  |
| AF-615 is a novel Inhibitor of CDT1/Geminin Protein Complex, promoting DNA Damage and | ||||
| 24134 | AkaLumine HCl | 2558205-28-8 | 98% Min. |  |
| AkaLumine is a luciferin analogue. The bioluminescence produced by AkaLumine in react | ||||
| 24122 | Azenosertib | 2376146-48-2 | 98% Min. |  |
| Azenosertib, also known as ZN-c3, is a highly selective Wee1 inhibitor (ICV50 = 3.8 n | ||||
| 24114 | Arimoclomol citrate | 368860-21-3 | 98% Min. |  |
| Arimoclomol citrate is a heat shock protein amplifier potentially useful for the trea | ||||
| 24088 | ART-446 | 2984543-29-3 | 98% Min. |  |
| 24070 | AZD-1656 | 919783-22-5 | 98% Min. |  |
| AZD-1656 is a glucokinase (GK) activator potentially for the treatment of type 2 diab | ||||
| 24068 | Acoramidis hydrochloride | 2242751-53-5 | ≧98.0% |  |
| Acoramidis is an oral, potent, and highly selective small molecule transthyretin (TTR | ||||